Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. - Wikidata - awgldk - TriplyDB

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.

http://www.wikidata.org/entity/Q38449001

about

Epigenetics of colorectal cancer Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications The immunogenicity of colorectal cancers with high-degree microsatellite instability Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy Pharmacologic resistance in colorectal cancer: a review Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer Tumor-specific microsatellite instability: do distinct mechanisms underlie the MSI-L and EMAST phenotypes?EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth.Utility of p16 immunohistochemistry for the identification of Lynch syndrome Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.A shift from distal to proximal neoplasia in the colon: a decade of polyps and CRC in Italy The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients.Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer.Genomic and epigenetic instability in colorectal cancer pathogenesis.Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts Microsatellite instability and survival in rectal cancer.5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.Both hMutSα and hMutSß DNA mismatch repair complexes participate in 5-fluorouracil cytotoxicity.Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics?A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.Evidence for an hMSH3 defect in familial hamartomatous polyps.Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAF(V600E) in Patients with Lymph Node-Positive Colon Cancer

P2860

Q24598045-2FC5A423-223C-475D-AD07-D9180CD351EE Q24610838-EF03752C-BC9A-4070-B47E-6D6D0D984AC7 Q24814928-3F782815-D6CB-4652-8184-9EF4F637EAF8 Q26751035-28321C72-3C6C-4DA9-AC0D-455D256A0C06 Q26769850-83BC8091-39EE-4FD0-A1E0-140898880100 Q26797255-B42FE34C-A540-459D-B8D9-716E3B1F21A3 Q26864622-9B982FD3-A6AF-4425-908D-F189106D513E Q26995653-3179061A-0AEB-4DC4-9844-6E4A2B1265A0 Q28070038-79B42B99-5E12-4166-93DE-CE492C653D58 Q28084346-A7062DE4-AE1C-4B97-83E3-5CDEC110E77F Q28247135-DC2EE9DD-5797-45BE-8A81-1CE47FA879E6 Q28253670-4B55BDA4-2206-4742-A764-8E8C25D2B678 Q28286398-1BDC343A-AF7F-4CDA-9C1E-1A7E7C1122E3 Q33213711-9D3367FD-BCEC-4A97-A4D8-2BDDB0D1595A Q33383621-2D2C021D-48FA-4C30-B8C6-031AE742EB61 Q33401080-AF79627B-1336-4AE2-80C3-2B7FF34F6F6D Q33586020-A34BBC07-DBFF-4CC6-AA0C-0FA05A9D1CFA Q33632100-F0889A57-7F5A-4000-8C52-4456DB7F2147 Q33675252-C45E7541-DFC8-4D19-9ACF-124AB1C8DC96 Q33725467-6D80537C-611C-4174-87BC-13B3F09B1CC2 Q33756141-68F8E6AE-DEFB-4FA8-B089-9F61679EC8C1 Q33762979-6867E89F-E356-4D8C-9387-9E5757902021 Q33791731-C26C3F2A-CDFC-45C1-8789-66CCD6F58F8F Q33792250-E978263E-1497-46DC-8324-B4487BF38682 Q33793501-1278D19A-1E45-42C1-B050-C3121BEE4E30 Q33836026-ABC5E117-F638-4860-8C83-92E937D7BBF1 Q33862772-8CFEE83C-C57C-4B36-9403-BE72C51E5F35 Q33939068-1B4627CE-84F9-4E6E-B6EC-E7DED2970925 Q33945019-30EF2977-CFDC-49F3-B4EF-B2E5F55678F5 Q33954707-ABD37E75-DE22-4611-91D7-7F66140E1358 Q34059750-F8967568-E962-4BC5-94A3-9038B83C48EF Q34099011-18D95241-7F55-4B3C-8851-3810CC46871D Q34131764-EAD65F60-B7B9-48D8-B843-2D077DCEF348 Q34138105-D754B882-F806-4CE7-9CE6-BA4FAD5ACA20 Q34138113-0D3A357F-7F57-4DA4-AB72-2083157216D1 Q34158885-39007E54-6AE3-404D-99AC-74232B4A944D Q34293192-45EC4320-482F-49E6-9C49-0E95BD030814 Q34408875-1AAC8256-5749-4F17-B0D7-64E7434ABD34 Q34420082-9129CD50-B3E2-4E1B-B472-FA89AF50CDAF Q34472453-242AFC83-88EB-429A-BF37-DA79C051CC6E

P2860

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.

http://www.wikidata.org/entity/Q38449001

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.

@en

type

label

Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.

@en

prefLabel

Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.

@en

P1433

Q38449001-57041186-50AB-4859-B24A-BD762E4A3C84

P1476

Q38449001-1B3CCB9C-E653-45F5-959F-6E24D9BA3CB0

P2093

Q38449001-008CF69A-B904-4421-81BA-4CAA06F86D6B

Q38449001-0216C8A9-DFFD-4616-8BA9-2B89D7A8D70F

Q38449001-15423069-8942-4F3C-B0DE-E0ABC236E8EA

Q38449001-1D111D19-1C5A-4D85-B29C-22564EC03A25

Q38449001-2FA7C485-CA5F-43B8-89DE-D0BC15DD2481

Q38449001-6B45B0D1-32A0-4037-9CF6-28EC46F39689

Q38449001-9E9337F6-C469-48CA-BA6F-53717FC3F6A0

Q38449001-ACDB1F1A-E479-4C6F-BA8C-5EB182EB76E6

Q38449001-C0BC84E4-7AC7-4EB9-B7F8-6719EFB3DB08

Q38449001-D7091CC4-0A58-4F47-B22D-8A9FA525A3F5

P304

Q38449001-F099DF92-C1C4-49D0-BA1C-C5B3216C06AD

P31

Q38449001-28F70841-1E5C-488E-8A48-9BD6CB8419E7

P356

Q38449001-19F8AC77-F094-4EAA-9851-56746AFF69E2

P407

Q38449001-66BA08D4-3DA6-4CBA-837C-E66F2D184FD4

P433

Q38449001-9B5C2585-8DA7-4447-A9A0-FFCFE9611FFD

P478

Q38449001-67292959-59DB-4FEA-8CFB-E0E9FCAE34F1

P577

Q38449001-DD6060BF-7B54-4F60-A2B9-9C2425B4AFA1

P698

Q38449001-9D5945FD-4A57-40B1-B1ED-F1FC254E2A1A

P921

Q38449001-045982E4-4E69-44DF-A991-970E3DC933BB

Q38449001-92024BC9-BEB5-441B-8BF3-6F677950191C

P356

J.GASTRO.2003.12.023

P1433

Gastroenterology

P1476

Use of 5-fluorouracil and surv ...... te-unstable colorectal cancer.

@en

P2093

Ajay Goel

http://www.w3.org/2001/XMLSchema#string

Akihiro Tajima

http://www.w3.org/2001/XMLSchema#string

Betty L Cabrera

http://www.w3.org/2001/XMLSchema#string

C Richard Boland

http://www.w3.org/2001/XMLSchema#string

Christian A Arnold

http://www.w3.org/2001/XMLSchema#string

Cynthia A Behling

http://www.w3.org/2001/XMLSchema#string

E Julieta Smith

http://www.w3.org/2001/XMLSchema#string

John M Carethers

http://www.w3.org/2001/XMLSchema#string

Katsumi Miyai

http://www.w3.org/2001/XMLSchema#string

Lanchinh Nguyen

http://www.w3.org/2001/XMLSchema#string

P304

394-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2003.12.023

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14762775

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer